dc.relation.reference | 1. Santos, F.A., et al., Brazilian propolis: physicochemical properties, plant origin and antibacterial activity on periodontopathogens. Phytother Res, 2003. 17(3): p. 285-9.
2. Pietta, P.G., C. Gardana, and A.M. Pietta, Analytical methods for quality control of propolis. Fitoterapia, 2002. 73 Suppl 1: p. S7-20.
3. Velikova, M., et al., Propolis from the Mediterranean region: chemical composition and antimicrobial activity. Z Naturforsch [C], 2000. 55(9-10): p. 790-3.
4. Pang, J.F. and S.S. Chen, [Treatment of oral leukoplakia with propolis: report of 45 cases]. Zhong Xi Yi Jie He Za Zhi, 1985. 5(8): p. 485-6, 452-3.
5. Khayyal, M.T., et al., A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients. Fundam Clin Pharmacol, 2003. 17(1): p. 93-102.
6. Grange, J.M. and R.W. Davey, Antibacterial properties of propolis (bee glue). J R Soc Med, 1990. 83(3): p. 159-60.
7. Huleihel, M. and V. Isanu, Anti-herpes simplex virus effect of an aqueous extract of propolis. Isr Med Assoc J, 2002. 4(11 Suppl): p. 923-7.
8. Rapta, P., et al., Redox intermediates of flavonoids and caffeic acid esters from propolis: an EPR spectroscopy and cyclic voltammetry study. Free Radic Biol Med, 1995. 18(5): p. 901-8.
9. Okonenko, L.B., [Propolis as an inhibitor of free radical lipid oxidation in salmonellosis]. Vopr Med Khim, 1986. 32(3): p. 45-8.
10. Ozen, S., et al., Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol, 2004. 24(1): p. 27-35.
11. Nakanishi, I., et al., Efficient radical scavenging ability of artepillin C, a major component of Brazilian propolis, and the mechanism. Org Biomol Chem, 2003. 1(9): p. 1452-4.
12. Han, S., et al., Activation of murine macrophage cell line RAW 264.7 by Korean propolis. Arch Pharm Res, 2002. 25(6): p. 895-902.
13. Tatefuji, T., et al., Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility. Biol Pharm Bull, 1996. 19(7): p. 966-70.
14. Luo, J., et al., PM-3, a benzo-gamma-pyran derivative isolated from propolis, inhibits growth of MCF-7 human breast cancer cells. Anticancer Res, 2001. 21(3B): p. 1665-71.
15. Kimoto, T., et al., Pulmonary carcinogenesis induced by ferric nitrilotriacetate in mice and protection from it by Brazilian propolis and artepillin C. Virchows Arch, 2001. 438(3): p. 259-70.
16. Havsteen, B.H., The biochemistry and medical significance of the flavonoids. Pharmacol Ther, 2002. 96(2-3): p. 67-202.
17. Amoros, M., et al., Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod, 1992. 55(12): p. 1732-40.
18. Halliwell, B., J. Rafter, and A. Jenner, Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr, 2005. 81(1 Suppl): p. 268S-276S.
19. Sahinler, N. and O. Kaftanoglu, Natural product propolis: chemical composition. Nat Prod Res, 2005. 19(2): p. 183-8.
20. Santos, F.A., et al., Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria. J Ethnopharmacol, 2002. 80(1): p. 1-7.
21. Steinberg, D., G. Kaine, and I. Gedalia, Antibacterial effect of propolis and honey on oral bacteria. Am J Dent, 1996. 9(6): p. 236-9.
22. Mirzoeva, O.K., R.N. Grishanin, and P.C. Calder, Antimicrobial action of propolis and some of its components: the effects on growth, membrane potential and motility of bacteria. Microbiol Res, 1997. 152(3): p. 239-46.
23. Koo, H., et al., In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch Oral Biol, 2000. 45(2): p. 141-8.
24. Park, Y.K., et al., Antimicrobial activity of propolis on oral microorganisms. Curr Microbiol, 1998. 36(1): p. 24-8.
25. Ikeno K, Ikeno T, Miyazawa C., Effects of propolis on dental caries in rats., Caries Res. 1991;25(5):347-51.
26. Sa-Nunes A, Faccioli LH, Sforcin JM., Propolis: lymphocyte proliferation and IFN-gamma production. J Ethnopharmacol. 2003 Jul;87(1):93-7.
27. Lin, S.C., et al., Hepatoprotective effects of Arctium lappa on carbon tetrachloride- and acetaminophen-induced liver damage. Am J Chin Med, 2000. 28(2): p. 163-73.
28. Lin, S.C., et al., The hepatoprotective effects of Solanum alatum Moench. on acetaminophen-induced hepatotoxicity in mice. Am J Chin Med, 2000. 28(1): p. 105-14.
29. Lin, S.C., et al., The hepatoprotective and therapeutic effects of propolis ethanol extract on chronic alcohol-induced liver injuries. Am J Chin Med, 1997. 25(3-4): p. 325-32.
30. Lin, S.C., et al., The influence of propolis ethanol extract on liver microsomal enzymes and glutathione after chronic alcohol administration. Am J Chin Med, 1999. 27(1): p. 83-93.
31. Choi, Y.H., et al., Apoptosis induced by propolis in human hepatocellular carcinoma cell line. Int J Mol Med, 1999. 4(1): p. 29-32.
32. Kimoto, T., et al., [Cell cycle and apoptosis in cancer induced by the artepillin C extracted from Brazilian propolis]. Gan To Kagaku Ryoho, 1996. 23(13): p. 1855-9.
33. Lu, L.C., Y.W. Chen, and C.C. Chou, Antibacterial activity of propolis against Staphylococcus aureus. Int J Food Microbiol, 2005. 102(2): p. 213-20.
34. Miorin, P.L., et al., Antibacterial activity of honey and propolis from Apis mellifera and Tetragonisca angustula against Staphylococcus aureus. J Appl Microbiol, 2003. 95(5): p. 913-20.
35. Krol, W., et al., Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of staphylococcus aureus. Arzneimittelforschung, 1993. 43(5): p. 607-9.
36. Shub, T.A., et al., [Effect of propolis on Staphylococcus aureus strains resistant to antibiotics]. Antibiotiki, 1981. 26(4): p. 268-71.
37. Koo, H., et al., Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. Antimicrob Agents Chemother, 2002. 46(5): p. 1302-9.
38. Bosio, K., et al., In vitro activity of propolis against Streptococcus pyogenes. Lett Appl Microbiol, 2000. 31(2): p. 174-7.
39. Keskin, N., et al., Antibacterial activity and chemical composition of Turkish propolis. Z Naturforsch [C], 2001. 56(11-12): p. 1112-5.
40. Yildirim, Z., et al., Effect of water extract of Turkish propolis on tuberculosis infection in guinea-pigs. Pharmacol Res, 2004. 49(3): p. 287-92.
41. Scheller, S., et al., Synergism between ethanolic extract of propolis (EEP) and anti-tuberculosis drugs on growth of mycobacteria. Z Naturforsch [C], 1999. 54(7-8): p. 549-53.
42. Hegazi, A.G. and F.K. El Hady, Egyptian propolis: 1-antimicrobial activity and chemical composition of Upper Egypt propolis. Z Naturforsch [C], 2001. 56(1-2): p. 82-8.
43. Orsi, R.O., et al., Effects of Brazilian and Bulgarian propolis on bactericidal activity of macrophages against Salmonella Typhimurium. Int Immunopharmacol, 2005. 5(2): p. 359-68.
44. Ota, C., et al., Antifungal activity of propolis on different species of Candida. Mycoses, 2001. 44(9-10): p. 375-8.
45. Koc, A.N., et al., Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay. Mycoses, 2005. 48(3): p. 205-10.
46. Huleihel, M. and V. Ishano, Effect of propolis extract on malignant cell transformation by moloney murine sarcoma virus. Arch Virol, 2001. 146(8): p. 1517-26.
47. Amoros, M., et al., Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. J Nat Prod, 1994. 57(5): p. 644-7.
48. Serkedjieva, J., N. Manolova, and V. Bankova, Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). J Nat Prod, 1992. 55(3): p. 294-302.
49. Debiaggi, M., et al., Effects of propolis flavonoids on virus infectivity and replication. Microbiologica, 1990. 13(3): p. 207-13.
50. Esanu, V., et al., The effect of an aqueous propolis extract, of rutin and of a rutin-quercetin mixture on experimental influenza virus infection in mice. Virologie, 1981. 32(3): p. 213-5.
51. Maichuk Iu, F., L.E. Orlovskaia, and V.P. Andreev, [The use of ocular drug films of propolis in the sequelae of ophthalmic herpes]. Voen Med Zh, 1995(12): p. 36-9, 80.
52. Drogovoz, S.M., et al., [The liver-protective properties of the pediatric drug form of propolis in animals of different age groups]. Eksp Klin Farmakol, 1994. 57(4): p. 39-42.
53. Garbuzova, V.M., [Drug forms of propolis prepared at home]. Med Sestra, 1988. 47(12): p. 48-51.
54. Tykhonov, O.I., [Ophthalmic drug films from the lyophilic phenolic substance of propolis]. Farm Zh, 1978(6): p. 56-8.
55. Kravchuk, P.O. and K.P. Rafal'skii, [Propolis as a drug]. Farm Zh, 1969. 24(5): p. 87-9.
56. Vynograd, N., I. Vynograd, and Z. Sosnowski, A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). Phytomedicine, 2000. 7(1): p. 1-6.
57. Martins, R.S., et al., Effect of commercial ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis. J Oral Sci, 2002. 44(1): p. 41-8.
58. Ito, J., et al., Anti-AIDS agents. 48.(1) Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis. J Nat Prod, 2001. 64(10): p. 1278-81.
59. Harish, Z., et al., Suppression of HIV-1 replication by propolis and its immunoregulatory effect. Drugs Exp Clin Res, 1997. 23(2): p. 89-96.
60. Semeja, Z., et al., Therapeutic value of flavonoids in Rhinovirus infections. Otolaryngologia Polska, 1989. 43(3): p. 180-4.
61. Spencer, J.V., et al., Structure of the herpes simplex virus capsid: peptide A862-H880 of the major capsid protein is displayed on the rim of the capsomer protrusions. Virology, 1997. 228(2): p. 229-35.
62. Mah, I., et al., Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples. Chinese J Microbiol Immunal, 1997. 30: p. 51-4.
63. Sibrack, C.D., et al., Barry pathogenicity of acyclovir-resistant herpes siplex virus type 1 form an immuno-deficient child. Journal of infectious disease, 1982. 146(5): p. 673-682.
64. Kujumgiev, A., et al., Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol, 1999. 64(3): p. 235-40.
65. Bernard Roizman and Patricia L. Ward , Herpesviridae, Alphaherpesvirinae, Simplexvirus, p.399-p.407 , In C. A. Tidona, and G.Darai(ed.), The Springer Index of Viruses. Springer
66. Nora M. Chapman and Steven M. Tracy, Picornaviridae, Enterovirus, Poliovirus, p.755-p.764 , In C. A. Tidona, and G.Darai(ed.), The Springer Index of Viruses. Springer
67. Wade JC, M.C., Mayers JD, Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple ciurses of treatment with acyclovir. J Inffect Dis, 1983. 148: p. 1077-1082.
68. Dumitrescu M, Crisan I, Esanu V., The mechanism of the antiherpetic action of an aqueous propolis extract. II. [Article in French]
The action of the lectins of an aqueous propolis extract Rev Roum Virol. 1993 Jan-Jun;44(1-2):49-54.
69. Dumitrescu M, Esanu V, Crisan I., The mechanisms of the antiherpetic action of aqueous propolis extracts. I. The antioxidant action on human fibroblast cultures][Article in French] Spencer, Rev Roum Virol. 1992 Jul-Dec;43(3-4):165-73.
70. Esanu V., Recent advances in the chemotherapy of herpes virus infections. Virologie. 1981 Jan –Mar;32(1):57-77 | en |